Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
13.80
-0.80 (-5.48%)
At close: Dec 10, 2025, 4:00 PM EST
14.00
+0.20 (1.45%)
After-hours: Dec 10, 2025, 7:10 PM EST
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $746.83 million as of December 10, 2025. Its market cap has increased by 326.03% in one year.
Market Cap
746.83M
Enterprise Value
553.20M
1-Year Change
326.03%
Ranking
Category
Stock Price
$13.80
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $746.83M, an increase of 147.59%. That is a compound annual growth rate of 15.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 746.83M | 194.60% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | 319.46M | -14.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.69B |
| Johnson & Johnson | 497.62B |
| AbbVie | 397.98B |
| UnitedHealth Group | 297.45B |
| AstraZeneca | 279.37B |
| Novartis AG | 251.91B |
| Merck & Co. | 242.30B |
| Thermo Fisher Scientific | 215.59B |